Andrew L. Mammen - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 

160 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Musai J, Mammen AL, Pinal-Fernandez I. Recent Updates on the Pathogenesis of Inflammatory Myopathies. Current Rheumatology Reports. PMID 39316320 DOI: 10.1007/s11926-024-01164-7  0.562
2024 Najjar R, Alessi H, Pinal-Fernandez I, Mammen AL, Mustelin T. Distinct Transcript-Level Expression Profiles and Unique Alternative Splicing in Inflammatory Myopathies. Acr Open Rheumatology. PMID 39073022 DOI: 10.1002/acr2.11724  0.55
2024 Abad C, Pinal-Fernandez I, Guillou C, Bourdenet G, Drouot L, Cosette P, Giannini M, Debrut L, Jean L, Bernard S, Genty D, Zoubairi R, Remy-Jouet I, Geny B, Boitard C, ... Mammen A, et al. IFNγ causes mitochondrial dysfunction and oxidative stress in myositis. Nature Communications. 15: 5403. PMID 38926363 DOI: 10.1038/s41467-024-49460-1  0.555
2024 Pinal-Fernandez I, Muñoz-Braceras S, Casal-Dominguez M, Pak K, Torres-Ruiz J, Musai J, Dell'Orso S, Naz F, Islam S, Gutierrez-Cruz G, Cano MD, Matas-Garcia A, Padrosa J, Tobias-Baraja E, Garrabou G, ... ... Mammen AL, et al. Pathological autoantibody internalisation in myositis. Annals of the Rheumatic Diseases. PMID 38902010 DOI: 10.1136/ard-2024-225773  0.72
2024 Jayan A, Mammen AL, Suarez-Almazor ME. Immune Checkpoint Inhibitor-induced Myositis. Rheumatic Diseases Clinics of North America. 50: 281-290. PMID 38670726 DOI: 10.1016/j.rdc.2024.02.003  0.301
2024 Loganathan A, Zanframundo G, Yoshida A, Faghihi-Kashani S, Bauer Ventura I, Dourado E, Bozan F, Sambataro G, Yamano Y, Bae SS, Lim D, Ceribelli A, Isailovic N, Selmi C, Fertig N, ... ... Mammen AL, et al. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank. Clinical and Experimental Rheumatology. 42: 277-287. PMID 38488094 DOI: 10.55563/clinexprheumatol/s14zq8  0.539
2024 Torres-Ruiz J, Pinal-Fernandez I, Selva-O'Callaghan A, Campbell B, Muñoz-Braceras S, Mejía-Domínguez NR, Núñez-Álvarez C, Milisenda J, Casal-Domínguez M, Pak K, Guillén-Del-Castillo A, Trallero-Araguas E, Gil-Vila A, Mammen AL. Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. 42: 367-376. PMID 38488092 DOI: 10.55563/clinexprheumatol/l9gudh  0.725
2024 Walitt B, Singh K, LaMunion SR, Hallett M, Jacobson S, Chen K, Enose-Akahata Y, Apps R, Barb JJ, Bedard P, Brychta RJ, Buckley AW, Burbelo PD, Calco B, Cathay B, ... ... Mammen AL, et al. Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome. Nature Communications. 15: 907. PMID 38383456 DOI: 10.1038/s41467-024-45107-3  0.542
2024 Pinal-Fernandez I, Muñoz-Braceras S, Casal-Dominguez M, Pak K, Torres-Ruiz J, Musai J, Dell'Orso S, Naz F, Islam S, Gutierrez-Cruz G, Cano MD, Matas-Garcia A, Padrosa J, Tobías-Baraja E, Garrabou G, ... ... Mammen AL, et al. Pathogenic autoantibody internalization in myositis. Medrxiv : the Preprint Server For Health Sciences. PMID 38313303 DOI: 10.1101/2024.01.15.24301339  0.718
2024 Kleefeld F, Horvath R, Pinal-Fernandez I, Mammen AL, Casal-Dominguez M, Hathazi D, Melchert S, Hahn K, Sickmann A, Muselmann-Genschow C, Hentschel A, Preuße C, Roos A, Schoser B, Stenzel W. Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2. Acta Neuropathologica. 147: 19. PMID 38240888 DOI: 10.1007/s00401-023-02673-y  0.567
2023 Lloyd TE, Michelle EH, Pinal-Fernandez I, Mammen AL. Author Response: Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis. Neurology. 101: 500. PMID 37696675 DOI: 10.1212/WNL.0000000000207784  0.561
2023 Muñoz-Braceras S, Pinal-Fernandez I, Casal-Dominguez M, Pak K, Milisenda JC, Lu S, Gadina M, Naz F, Gutierrez-Cruz G, Dell'Orso S, Torres-Ruiz J, Grau-Junyent JM, Selva-O'Callaghan A, Paik JJ, Albayda J, ... ... Mammen AL, et al. Identification of Unique microRNA Profiles in Different Types of Idiopathic Inflammatory Myopathy. Cells. 12. PMID 37681930 DOI: 10.3390/cells12172198  0.656
2023 Guerra NL, Matas-García A, Serra-García L, Morgado-Carrasco D, Padrosa J, Aldecoa I, Duque Y, Casal-Dominguez M, Muñoz-Braceras S, Aranega R, Moreno-Lozano P, Cantó-Santos J, Garrabou G, Ruiz-Ortiz E, Trallero-Araguas E, ... ... Mammen AL, et al. Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature. Autoimmunity Reviews. 22: 103375. PMID 37321468 DOI: 10.1016/j.autrev.2023.103375  0.489
2023 Pinal-Fernandez I, Milisenda JC, Pak K, Muñoz-Braceras S, Casal-Dominguez M, Torres-Ruiz J, Dell'Orso S, Naz F, Gutierrez-Cruz G, Duque-Jaimez Y, Matas-Garcia A, Padrosa J, Garcia-Garcia FJ, Guitart-Mampel M, Garrabou G, ... ... Mammen AL, et al. Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. Annals of the Rheumatic Diseases. PMID 37130727 DOI: 10.1136/ard-2023-223873  0.75
2023 Sherman MA, Pak K, Pinal-Fernandez I, Flegel WA, Targoff IN, Miller FW, Rider LG, Mammen AL. Anti-Sp4 autoantibodies co-occur with anti-TIF1 and are associated with distinct clinical features and immunogenetic risk factors in juvenile myositis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 36996276 DOI: 10.1002/art.42512  0.591
2023 Mammen AL, Amato AA, Dimachkie MM, Chinoy H, Hussain Y, Lilleker JB, Pinal-Fernandez I, Allenbach Y, Boroojerdi B, Vanderkelen M, Delicha EM, Koendgen H, Farzaneh-Far R, Duda PW, Sayegh C, et al. Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. Rheumatology. 5: e67-e76. PMID 36923454 DOI: 10.1016/s2665-9913(23)00003-6  0.595
2023 Pinal-Fernandez I, Quintana A, Milisenda JC, Casal-Dominguez M, Muñoz-Braceras S, Derfoul A, Torres-Ruiz J, Pak K, Dell'Orso S, Naz F, Gutierrez-Cruz G, Milone M, Shelly S, Duque-Jaimez Y, Tobias-Baraja E, ... ... Mammen AL, et al. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis. Annals of the Rheumatic Diseases. PMID 36801811 DOI: 10.1136/ard-2022-223792  0.707
2023 Nascimento A, Bruels CC, Donkervoort S, Foley AR, Codina A, Milisenda JC, Estrella EA, Li C, Pijuan J, Draper I, Hu Y, Stafki SA, Pais LS, Ganesh VS, O'Donnell-Luria A, ... ... Mammen AL, et al. Variants in DTNA cause a mild, dominantly inherited muscular dystrophy. Acta Neuropathologica. PMID 36799992 DOI: 10.1007/s00401-023-02551-7  0.569
2023 Casal-Dominguez M, Pinal-Fernandez I, Pak K, Muñoz-Braceras S, Milisenda JC, Torres-Ruiz J, Dell Orso S, Naz F, Gutierrez-Cruz G, Duque-Jaimez Y, Matas-Garcia A, Valls-Roca L, Garrabou G, Trallero-Araguas E, Walitt B, ... ... Mammen AL, et al. Coordinated local RNA overexpression of complement induced by interferon gamma in myositis. Scientific Reports. 13: 2038. PMID 36739295 DOI: 10.1038/s41598-023-28838-z  0.701
2023 Milisenda JC, Pinal-Fernandez I, Lloyd TE, Grau-Junyent JM, Christopher-Stine L, Corse AM, Mammen AL. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders. Rheumatology (Oxford, England). PMID 36707996 DOI: 10.1093/rheumatology/kead052  0.595
2023 Michelle EH, Pinal-Fernandez I, Casal-Dominguez M, Albayda J, Paik JJ, Tiniakou E, Adler B, Mecoli CA, Danoff SK, Christopher-Stine L, Mammen AL, Lloyd TE. Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis. Neurology. PMID 36690456 DOI: 10.1212/WNL.0000000000206777  0.567
2022 Hosono Y, Sie B, Pinal-Fernandez I, Pak K, Mecoli CA, Casal-Dominguez M, Warner BM, Kaplan MJ, Albayda J, Danoff S, Lloyd TE, Paik JJ, Tiniakou E, Aggarwal R, Oddis CV, ... ... Mammen AL, et al. Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies. Annals of the Rheumatic Diseases. PMID 36008132 DOI: 10.1136/ard-2022-222441  0.686
2022 Sherman MA, Graf R, Sabbagh SE, Galindo-Feria AS, Pinal-Fernandez I, Pak K, Kishi T, Flegel WA, Targoff IN, Miller FW, Lundberg IE, Rider LG, Mammen AL. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features. Rheumatology (Oxford, England). PMID 35961028 DOI: 10.1093/rheumatology/keac428  0.638
2022 Mammen AL. Statin-Associated Myalgias and Muscle Injury-Recognizing and Managing Both While Still Lowering the Low-Density Lipoprotein. Rheumatic Diseases Clinics of North America. 48: 445-454. PMID 35400370 DOI: 10.1016/j.rdc.2022.02.004  0.31
2022 Zanframundo G, Faghihi-Kashani S, Scirè CA, Bonella F, Corte TJ, Doyle TJ, Fiorentino D, Gonzalez-Gay MA, Hudson M, Kuwana M, Lundberg IE, Mammen A, McHugh N, Miller FW, Monteccucco C, et al. Defining anti-synthetase syndrome: a systematic literature review. Clinical and Experimental Rheumatology. 40: 309-319. PMID 35225224  0.537
2022 Ikenaga C, Date H, Kanagawa M, Mitsui J, Ishiura H, Yoshimura J, Pinal-Fernandez I, Mammen AL, Lloyd TE, Tsuji S, Shimizu J, Toda T, Goto J. Muscle Transcriptomics Shows Overexpression of Cadherin 1 in Inclusion Body Myositis. Annals of Neurology. PMID 35064929 DOI: 10.1002/ana.26304  0.57
2022 Britson KA, Ling JP, Braunstein KE, Montagne JM, Kastenschmidt JM, Wilson A, Ikenaga C, Tsao W, Pinal-Fernandez I, Russell KA, Reed N, Mozaffar T, Wagner KR, Ostrow LW, Corse AM, ... Mammen AL, et al. Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis. Science Translational Medicine. 14: eabi9196. PMID 35044790 DOI: 10.1126/scitranslmed.abi9196  0.674
2021 Casal-Dominguez M, Pinal-Fernandez I, Mammen AL. Inhibiting interferon pathways in dermatomyositis: rationale and preliminary evidence. Current Treatment Options in Rheumatology. 7: 258-271. PMID 37456764 DOI: 10.1007/s40674-021-00182-1  0.579
2021 Mammen AL, Pinal-Fernandez I, Rider LG. Conflicting reports of anti-NT5C1a autoantibodies in juvenile myositis: Comment on the article by Rietveld et al. Arthritis & Rheumatology (Hoboken, N.J.). PMID 34962359 DOI: 10.1002/art.42059  0.499
2021 Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, Mammen AL, Miller FW. Idiopathic inflammatory myopathies. Nature Reviews. Disease Primers. 7: 86. PMID 34857798 DOI: 10.1038/s41572-021-00321-x  0.307
2021 Amici DR, Pinal-Fernandez I, Christopher-Stine L, Mammen AL, Mendillo ML. A network of core and subtype-specific gene expression programs in myositis. Acta Neuropathologica. PMID 34499219 DOI: 10.1007/s00401-021-02365-5  0.611
2021 Casal-Dominguez M, Pinal-Fernandez I, Pak K, Huang W, Selva-O'Callaghan A, Albayda J, Casciola-Rosen L, Paik JJ, Tiniakou E, Mecoli CA, Lloyd TE, Danoff SK, Christopher-Stine L, Mammen AL. Performance of the 2017 EULAR/ACR classification criteria for inflammatory myopathies in patients with myositis-specific autoantibodies. Arthritis & Rheumatology (Hoboken, N.J.). PMID 34480833 DOI: 10.1002/art.41964  0.731
2021 Pinal-Fernandez I, Pak K, Gil-Vila A, Baucells A, Plotz B, Casal-Dominguez M, Derfoul A, Angeles Martinez M, Selva-O'Callaghan A, Sabbagh S, Casciola-Rosen L, Albayda J, Paik J, Tiniakou E, Danoff SK, ... ... Mammen AL, et al. Anti-cortactin autoantibodies are associated with key clinical features in adult myositis but are rarely present in juvenile myositis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 34313394 DOI: 10.1002/art.41931  0.686
2021 Casal-Dominguez M, Pinal-Fernandez I, Derfoul A, Graf R, Michelle H, Albayda J, Tiniakou E, Adler B, Danoff SK, Lloyd TE, Christoper-Stine L, Paik JJ, Mammen AL. The phenotype of myositis patients with anti-Ku autoantibodies. Seminars in Arthritis and Rheumatism. 51: 728-734. PMID 34144382 DOI: 10.1016/j.semarthrit.2021.04.012  0.601
2021 Sabbagh SE, Pinal-Fernandez I, Casal-Dominguez M, Albayda J, Paik JJ, Miller FW, Rider LG, Mammen AL, Christopher-Stine L. Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis. Clinical Rheumatology. PMID 33851273 DOI: 10.1007/s10067-021-05730-7  0.595
2021 Pinal-Fernandez I, Mammen AL. Myositis-specific autoantibodies as relevant adjusting variables in myositis research. Arthritis & Rheumatology (Hoboken, N.J.). PMID 33645884 DOI: 10.1002/art.41705  0.598
2021 Mammen AL. Statin-Associated Myalgias and Muscle Injury-Recognizing and Managing Both While Still Lowering the Low-Density Lipoprotein. The Medical Clinics of North America. 105: 263-272. PMID 33589101 DOI: 10.1016/j.mcna.2020.10.004  0.31
2021 Pinal-Fernandez I, Casal-Dominguez M, Milisenda JC, Mammen AL. Response to: 'Correspondence on 'Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis'' by Takanashi . Annals of the Rheumatic Diseases. PMID 33441300 DOI: 10.1136/annrheumdis-2020-219767  0.568
2020 Milisenda JC, Pinal-Fernandez I, Lloyd TE, Grau JM, Miller FW, Selva-O'Callaghan A, Christopher-Stine L, Stenzel W, Mammen AL, Corse AM. Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies. Clinical and Experimental Rheumatology. PMID 32896253  0.69
2020 Casal-Dominguez M, Pinal-Fernandez I, Pak K, Marin-Sanchez A, Sanz-Martinez MT, Baucells A, Hosono Y, Christopher-Stine L, Mammen AL. The indirect immunofluorescence assay autoantibody profiles of myositis patients without known myositis-specific autoantibodies. Clinical and Experimental Rheumatology. PMID 32896249  0.575
2020 Montagne JM, Zheng XA, Pinal-Fernandez I, Milisenda JC, Christopher-Stine L, Lloyd TE, Mammen AL, Larman HB. Ultra-efficient sequencing of T Cell receptor repertoires reveals shared responses in muscle from patients with Myositis. Ebiomedicine. 59: 102972. PMID 32891935 DOI: 10.1016/J.Ebiom.2020.102972  0.605
2020 Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, Pak K, Miller FW, Milisenda JC, Grau-Junyent JM, Selva-O'Callaghan A, Carrion-Ribas C, Paik JJ, Albayda J, Christopher-Stine L, Lloyd TE, Corse AM, Mammen AL. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis. Annals of the Rheumatic Diseases. PMID 32546599 DOI: 10.1136/Annrheumdis-2019-216599  0.745
2020 Seto NL, Torres-Ruiz JJ, Carmona-Rivera C, Pinal-Fernandez I, Pak K, Purmalek MM, Hosono Y, Fernandes-Cerqueira C, Gowda PC, Arnett N, Gorbach A, Benveniste O, Gómez-Martín D, Selva-O'Callaghan A, Milisenda JC, ... ... Mammen AL, et al. Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies. Jci Insight. PMID 31945019 DOI: 10.1172/Jci.Insight.134189  0.735
2020 Espinosa-Ortega F, Holmqvist M, Dastmalchi M, Mammen A, Lundberg IE, Alexanderson H. Thu0343 Autoantibodies Can Partly Predict Severity Of Damage But Not Extent In Patients With Idiopathic Inflammatory Myositis Annals of the Rheumatic Diseases. 79: 402-403. DOI: 10.1136/Annrheumdis-2020-Eular.5086  0.345
2019 Parks CA, Pak K, Pinal-Fernandez I, Huang W, Derfoul A, Mammen AL. Trim33 (Tif1γ) is not required for skeletal muscle development or regeneration but suppresses cholecystokinin expression. Scientific Reports. 9: 18507. PMID 31811178 DOI: 10.1038/S41598-019-54651-8  0.631
2019 Pinal-Fernandez I, Pak K, Casal-Dominguez M, Hosono Y, Mecoli C, Christopher-Stine L, Mammen AL. Validation of anti-Mi2 autoantibody testing by line blot. Autoimmunity Reviews. 102425. PMID 31734399 DOI: 10.1016/J.Autrev.2019.102425  0.56
2019 Pinal-Fernandez I, Mammen AL. Case 22-2019: A 65-Year-Old Woman with Myopathy. The New England Journal of Medicine. 381: 1693-1694. PMID 31644863 DOI: 10.1056/NEJMc1911058#sa2  0.475
2019 Pinal-Fernandez I, Mecoli CA, Casal-Dominguez M, Pak K, Hosono Y, Huapaya J, Huang W, Albayda J, Tiniakou E, Paik JJ, Johnson C, Danoff SK, Corse AM, Christopher-Stine L, Mammen AL. More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies. Neurology. PMID 31594859 DOI: 10.1212/WNL.0000000000008443  0.68
2019 Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, Pak K, Plotz P, Miller FW, Milisenda JC, Grau-Junyent JM, Selva-O'Callaghan A, Paik J, Albayda J, Christopher-Stine L, Lloyd TE, Corse AM, Mammen AL. Identification of distinctive interferon gene signatures in different types of myositis. Neurology. PMID 31434690 DOI: 10.1212/Wnl.0000000000008128  0.726
2019 Mecoli CA, Casal-Dominguez M, Pak K, Pinal-Fernandez I, Albayda J, Tiniakou E, Paik JJ, Zahid U, Danoff SK, Mammen AL, Casciola-Rosen L, Christopher-Stine L. Myositis Autoantibodies: A Comparison of Results from the Oklahoma Medical Research Foundation Myositis Panel to the Euroimmun Research Line Blot. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31430029 DOI: 10.1002/art.41088  0.525
2019 Fischer N, Preuße C, Radke J, Pehl D, Allenbach Y, Schneider U, Feist E, von Casteleyn V, Hahn K, Ruck T, Meuth SG, Goebel HH, Graf R, Mammen A, Benveniste O, et al. Sequestosome-1 (P62) expression reveals chaperone-assisted selective autophagy in immune mediated necrotizing myopathies. Brain Pathology (Zurich, Switzerland). PMID 31376301 DOI: 10.1111/bpa.12772  0.411
2019 Huapaya JA, Silhan L, Pinal-Fernandez I, Casal-Dominguez M, Johnson C, Albayda J, Paik JJ, Abanti S, Mammen AL, Christopher-Stine L, Danoff SK. Long-term treatment with azathioprine and mycophenolate mofetil for myositis-related interstitial lung disease. Chest. PMID 31238042 DOI: 10.1016/J.Chest.2019.05.023  0.558
2019 Pinal-Fernandez I, Mammen AL. On using machine learning algorithms to define clinically meaningful patient subgroups. Annals of the Rheumatic Diseases. PMID 31227486 DOI: 10.1136/Annrheumdis-2019-215852  0.612
2019 Sabbagh S, Pinal Fernandez I, Miller FW, Rider LG, Mammen AL. Response to: 'response to: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S by Yang . Annals of the Rheumatic Diseases. PMID 31208959 DOI: 10.1136/Annrheumdis-2019-215693  0.346
2019 Huapaya JA, Hallowell R, Silhan L, Pinal-Fernandez I, Casal-Dominguez M, Johnson C, Albayda J, Paik JJ, Lin CT, Hussien A, Mammen AL, Christopher-Stine L, Danoff SK. Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease. Respiratory Medicine. 154: 6-11. PMID 31176796 DOI: 10.1016/J.Rmed.2019.05.012  0.575
2019 Mammen AL. Treatment of Refractory Anti-HMG-CoA Reductase Myopathy: A Role for Rituximab? The Journal of Rheumatology. 46: 550-551. PMID 31154443 DOI: 10.3899/jrheum.181392  0.44
2019 Rothwell S, Chinoy H, Lamb JA, Miller FW, Rider LG, Wedderburn LR, McHugh NJ, Mammen AL, Betteridge ZE, Tansley SL, Bowes J, Vencovský J, Deakin CT, Dankó K, Vidya L, et al. Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups. Annals of the Rheumatic Diseases. PMID 31138531 DOI: 10.1136/Annrheumdis-2019-215046  0.624
2019 Casal-Dominguez M, Pinal-Fernandez I, Huapaya J, Albayda J, Paik JJ, Johnson C, Silhan L, Mammen AL, Danoff SK, Christopher-Stine L. Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome. Clinical and Experimental Rheumatology. PMID 31074729  0.578
2019 Tiniakou E, Rivera E, Mammen AL, Christopher-Stine L. Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors in statin-associated immune mediated necrotizing myopathy: a case-series. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31058470 DOI: 10.1002/art.40919  0.331
2019 Pinal-Fernandez I, Mammen AL. Amyloid-PET: a new tool for diagnosing IBM? Nature Reviews. Rheumatology. PMID 31048779 DOI: 10.1038/S41584-019-0223-9  0.587
2019 Sabbagh S, Pinal-Fernandez I, Kishi T, Targoff IN, Miller FW, Rider LG, Mammen AL. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Annals of the Rheumatic Diseases. PMID 31018961 DOI: 10.1136/Annrheumdis-2018-215004  0.646
2019 Brusca RM, Pinal-Fernandez I, Psoter K, Paik JJ, Albayda J, Mecoli C, Tiniakou E, Mammen AL, Christopher-Stine L, Danoff S, Johnson C. The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease. Respiratory Medicine. 150: 63-65. PMID 30961952 DOI: 10.1016/J.Rmed.2019.02.015  0.568
2019 Pinal-Fernandez I, Amici DR, Parks CA, Derfoul A, Casal-Dominguez M, Pak K, Yeker R, Plotz P, Milisenda JC, Grau-Junyent JM, Selva-O'Callaghan A, Paik J, Albayda J, Corse AM, Lloyd TE, ... ... Mammen AL, et al. Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30861336 DOI: 10.1002/art.40883  0.735
2019 Casal-Dominguez M, Pinal-Fernandez I, Corse AM, Paik J, Albayda J, Casciola-Rosen L, Johnson C, Danoff SK, Christopher-Stine L, Tiniakou E, Mammen AL. Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies. Neurology. PMID 30824556 DOI: 10.1212/Wnl.0000000000007188  0.641
2019 Pinal-Fernandez I, Kroodsma CT, Mammen AL. Successful treatment of refractory mechanic's hands with ustekinumab in a patient with the antisynthetase syndrome. Rheumatology (Oxford, England). PMID 30793759 DOI: 10.1093/Rheumatology/Kez020  0.569
2019 Randazzo D, Khalique U, Belanto JJ, Kenea A, Talsness DM, Olthoff JT, Tran MD, Zaal KJ, Pak K, Pinal-Fernandez I, Mammen AL, Sackett D, Ervasti JM, Ralston E. Persistent upregulation of the β-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle. Human Molecular Genetics. PMID 30753428 DOI: 10.1093/Hmg/Ddz035  0.63
2019 Mohassel P, Landon-Cardinal O, Foley AR, Donkervoort S, Pak KS, Wahl C, Shebert RT, Harper A, Fequiere P, Meriggioli M, Toro C, Drachman D, Allenbach Y, Benveniste O, Béhin A, ... ... Mammen AL, et al. Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e523. PMID 30588482 DOI: 10.1212/NXI.0000000000000523  0.389
2018 Randazzo D, Khalique U, Belanto JJ, Kenea A, Talsness DM, Olthoff JT, Tran MD, Zaal KJ, Pak K, Pinal-Fernandez I, Mammen AL, Sackett D, Ervasti JM, Ralston E. Persistent upregulation of the β-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle. Human Molecular Genetics. PMID 30535187 DOI: 10.1093/hmg/ddy418  0.592
2018 Mammen AL, Rajan A, Pak K, Lehky T, Casciola-Rosen L, Donahue RN, Lepone LM, Zekeridou A, Pittock SJ, Hassan R, Schlom J, Gulley JL. Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1. Annals of the Rheumatic Diseases. PMID 30185415 DOI: 10.1136/annrheumdis-2018-213777  0.341
2018 Pinal-Fernandez I, Mammen AL. Dermatomyositis etiopathogenesis: a rebel soldier in the muscle. Current Opinion in Rheumatology. PMID 30148802 DOI: 10.1097/Bor.0000000000000540  0.638
2018 Selva-O'Callaghan A, Pinal-Fernandez I, Trallero-Araguás E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. The Lancet. Neurology. 17: 816-828. PMID 30129477 DOI: 10.1016/S1474-4422(18)30254-0  0.753
2018 Amici DR, Pinal-Fernandez I, Pagkatipunan R, Mears A, De Lorenzo R, Tiniakou E, Albayda J, Paik JJ, Lloyd TE, Christopher-Stine L, Mammen AL, Chung T. Muscle endurance deficits in myositis patients despite normal manual muscle testing scores. Muscle & Nerve. PMID 30028529 DOI: 10.1002/Mus.26307  0.649
2018 Brunham LR, Baker S, Mammen A, Mancini GBJ, Rosenson RS. Role of Genetics in the Prediction of Statin-Associated Muscle Symptoms and Optimization of Statin Use and Adherence. Cardiovascular Research. PMID 29878063 DOI: 10.1093/cvr/cvy119  0.345
2018 De Lorenzo R, Pinal-Fernandez I, Huang W, Albayda J, Tiniakou E, Johnson C, Milisenda JC, Casal-Dominguez M, Corse AM, Danoff SK, Christopher-Stine L, Paik JJ, Mammen AL. Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies. Neurology. PMID 29728522 DOI: 10.1212/Wnl.0000000000005638  0.643
2018 Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-Mediated Necrotizing Myopathy. Current Rheumatology Reports. 20: 21. PMID 29582188 DOI: 10.1007/S11926-018-0732-6  0.662
2018 Mohassel P, Mammen AL. Anti-HMGCR Myopathy. Journal of Neuromuscular Diseases. 5: 11-20. PMID 29480216 DOI: 10.3233/JND-170282  0.45
2018 Leung DG, Cohen JS, Michelle EH, Bai R, Mammen AL, Christopher-Stine L. Mitochondrial DNA Deletions With Low-Level Heteroplasmy in Adult-Onset Myopathy. Journal of Clinical Neuromuscular Disease. 19: 117-123. PMID 29465611 DOI: 10.1097/CND.0000000000000200  0.315
2018 Yeker RM, Pinal-Fernandez I, Kishi T, Pak K, Targoff IN, Miller FW, Rider LG, Mammen AL. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Annals of the Rheumatic Diseases. PMID 29363513 DOI: 10.1136/Annrheumdis-2017-212436  0.641
2018 Parikh P, Tavee J, Soltanzadeh P, Mammen AL, McKeever P, Li Y. Anti-HMGCR autoantibody positive necrotizing autoimmune myopathy with dermatomyositis-like eruption. Muscle & Nerve. PMID 29346706 DOI: 10.1002/Mus.26072  0.355
2017 Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Statins: pros and cons. Medicina Clinica. PMID 29292104 DOI: 10.1016/J.Medcli.2017.11.030  0.553
2017 Mammen AL. Which nonautoimmune myopathies are most frequently misdiagnosed as myositis? Current Opinion in Rheumatology. PMID 28832350 DOI: 10.1097/BOR.0000000000000441  0.329
2017 Paik JJ, Wigley FM, Shah AA, Corse AM, Casciola-Rosen L, Hummers LK, Mammen AL. Fibrosing myopathy in systemic sclerosis associates with higher mortality. Arthritis Care & Research. PMID 28544788 DOI: 10.1002/acr.23291  0.444
2017 Cox JT, Gullotti DM, Mecoli CA, Lahouti AH, Albayda J, Paik J, Johnson C, Danoff SK, Mammen AL, Christopher-Stine L. "Hiker's feet": a novel cutaneous finding in the inflammatory myopathies. Clinical Rheumatology. PMID 28389987 DOI: 10.1007/s10067-017-3598-5  0.351
2017 Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA, Albayda J, Paik JJ, Johnson C, Silhan L, Christopher-Stine L, Mammen AL, Danoff SK. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies. Rheumatology (Oxford, England). PMID 28339994 DOI: 10.1093/Rheumatology/Kex021  0.645
2017 Amici DR, Pinal-Fernandez I, Mázala DA, Lloyd TE, Corse AM, Christopher-Stine L, Mammen AL, Chin ER. Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis. Acta Neuropathologica Communications. 5: 24. PMID 28330496 DOI: 10.1186/S40478-017-0427-7  0.594
2017 Lloyd TE, Pinal-Fernandez I, Michelle EH, Christopher-Stine L, Pak K, Sacktor N, Mammen AL. Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients. Neurology. PMID 28283597 DOI: 10.1212/Wnl.0000000000003821  0.548
2017 Kishi T, Rider LG, Pak K, Barillas-Arias L, Henrickson M, McCarthy PL, Shaham B, Weiss PF, Horkayne-Szakaly I, Ira N Targoff, Miller F, Mammen AL. Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies are Associated with DRB1*07:01 and Severe Myositis in Pediatric Myositis Patients. Arthritis Care & Research. PMID 28129483 DOI: 10.1002/Acr.23113  0.44
2017 Weihl CC, Mammen AL. Sporadic Inclusion Body Myositis: A myodegenerative disease or an inflammatory myopathy. Neuropathology and Applied Neurobiology. PMID 28111778 DOI: 10.1111/nan.12384  0.427
2017 Tiniakou E, Pinal-Fernandez I, Lloyd TE, Albayda J, Paik J, Werner JL, Parks CA, Casciola-Rosen L, Christopher-Stine L, Mammen AL. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford, England). PMID 28096458 DOI: 10.1093/Rheumatology/Kew470  0.645
2017 Albayda J, Pinal-Fernandez I, Huang W, Parks C, Paik J, Casciola-Rosen L, Danoff SK, Johnson C, Christopher-Stine L, Mammen AL. Dermatomyositis Patients with Anti-Nuclear Matrix Protein-2 Autoantibodies Have More Edema, More Severe Muscle Disease, and Increased Malignancy Risk. Arthritis Care & Research. PMID 28085235 DOI: 10.1002/Acr.23188  0.677
2017 Mohassel P, Foley AR, Donkervoort S, Fequiere PR, Pak K, Bönnemann CG, Mammen AL. Anti-HMGCR necrotizing myopathy masquerading as a muscular dystrophy in a child. Muscle & Nerve. PMID 28066895 DOI: 10.1002/mus.25567  0.393
2017 Yeker R, Pinal-Fernandez I, Kishi T, Targoff I, Miller F, Rider L, Mammen A. SAT0376 ANTI-NT5C1A autoantibodies are frequent in juvenile myositis and associated with increased illness severity Annals of the Rheumatic Diseases. 76: 913-914. DOI: 10.1136/Annrheumdis-2017-Eular.6246  0.651
2017 Pinal-Fernandez I, Huang W, Casal-Dominguez M, Tiniakou E, Parks C, Pak K, Albayda J, Paik J, Danoff S, Christopher-Stine L, Mammen A. OP0038 Myositis autoantibodies outperform clinical subgroup classification in predicting muscle weakness in myositis patients Annals of the Rheumatic Diseases. 76: 67-67. DOI: 10.1136/Annrheumdis-2017-Eular.3476  0.649
2016 Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Annals of the Rheumatic Diseases. PMID 27651398 DOI: 10.1136/Annrheumdis-2016-210198  0.68
2016 Pinal-Fernandez I, Mammen AL. Spectrum of immune-mediated necrotizing myopathies and their treatments. Current Opinion in Rheumatology. PMID 27607340 DOI: 10.1097/Bor.0000000000000335  0.609
2016 Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi ME, Fritzler MJ, Schmeling H, et al. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Autoimmunity Reviews. PMID 27491568 DOI: 10.1016/J.Autrev.2016.07.023  0.458
2016 Basharat P, Lahouti AH, Paik JJ, Albayda J, Pinal-Fernandez I, Bichile T, Lloyd TE, Danoff SK, Casciola-Rosen L, Mammen AL, Christopher-Stine L. Statin-Induced Anti-HMGCR-Associated Myopathy. Journal of the American College of Cardiology. 68: 234-5. PMID 27386780 DOI: 10.1016/J.Jacc.2016.04.037  0.668
2016 Johnson C, Fernandez IP, Parikh R, Paik J, Albayda J, Mammen AL, Christopher-Stine L, Danoff S. Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease. Lung. PMID 27166633 DOI: 10.1007/S00408-016-9896-X  0.309
2016 Mammen A. Autoimmune muscle disease. Handbook of Clinical Neurology. 133: 467-84. PMID 27112692 DOI: 10.1016/B978-0-444-63432-0.00025-6  0.474
2016 Pinal-Fernandez I, Parks C, Werner JL, Albayda J, Paik J, Danoff S, Casciola-Rosen LA, Christopher-Stine L, Mammen AL. Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle. Arthritis Care & Research. PMID 27111848 DOI: 10.1002/Acr.22920  0.643
2016 Floyd JS, Brody JA, Tiniakou E, Psaty BM, Mammen A. Absence of anti-HMG-CoA reductase autoantibodies in severe self-limited statin-related myopathy. Muscle & Nerve. PMID 27038110 DOI: 10.1002/Mus.25127  0.393
2016 Mammen AL. Statin-Associated Autoimmune Myopathy. The New England Journal of Medicine. 374: 664-9. PMID 26886523 DOI: 10.1056/NEJMra1515161  0.306
2016 Pinal-Fernandez I, Casal-Dominguez M, Lahouti A, Basharat P, Albayda M, Paik J, Ahlawat S, Danoff S, Lloyd T, Mammen A, Carrino J, Christopher-Stine L. OP0010 Thigh Magnetic Resonance Imaging Reveals Increased Active and Chronic Muscle Damage in Necrotizing Myositis Compared To Polymyositis and Dermatomyositis Annals of the Rheumatic Diseases. 75: 56.2-56. DOI: 10.1136/Annrheumdis-2016-Eular.1177  0.652
2016 Pinal-Fernandez I, Parks C, Tiniakou E, Albayda M, Paik J, Lahouti A, Casal-Dominguez M, Pak K, Huang W, Lloyd T, Danoff S, Casciola-Rosen L, Christopher-Stine L, Mammen A. FRI0284 Anti-Srp-Associated Autoimmune Myopathy: Younger Age at Onset Is Associated with More Severe Disease and Worse Outcome Annals of the Rheumatic Diseases. 75: 538.1-538. DOI: 10.1136/Annrheumdis-2016-Eular.1176  0.66
2016 Tiniakou E, Fernandez IP, Christopher-Stine L, Werner J, Lloyd T, Paik J, Albayda J, Danoff S, Mammen A. FRI0273 Slow Recovery of Muscle Strength in Young Anti-HMG-COA Reductase Positive Myopathy Patients Annals of the Rheumatic Diseases. 75: 534-534. DOI: 10.1136/Annrheumdis-2016-Eular.1106  0.442
2015 Mammen AL, Casciola-Rosen L, Christopher-Stine L, Lloyd TE, Wagner KR. Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease. Neurology® Neuroimmunology & Neuroinflammation. 2: e172. PMID 26668818 DOI: 10.1212/NXI.0000000000000172  0.559
2015 Pinal-Fernandez I, Casciola-Rosen LA, Christopher-Stine L, Corse AM, Mammen AL. The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis. The Journal of Rheumatology. 42: 1448-54. PMID 26443871  0.635
2015 Tiniakou E, Mammen AL. Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review. Clinical Reviews in Allergy & Immunology. PMID 26429706 DOI: 10.1007/s12016-015-8511-x  0.474
2015 Michelle EH, Mammen AL. Myositis Mimics. Current Rheumatology Reports. 17: 63. PMID 26290112 DOI: 10.1007/s11926-015-0541-0  0.325
2015 Fiorentino DF, Presby M, Baer AN, Petri M, Rieger KE, Soloski M, Rosen A, Mammen AL, Christopher-Stine L, Casciola-Rosen L. PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome. Annals of the Rheumatic Diseases. PMID 26253095 DOI: 10.1136/Annrheumdis-2015-207509  0.369
2015 Mammen AL, Sartorelli V. IL-6 Blockade as a Therapeutic Approach for Duchenne Muscular Dystrophy. Ebiomedicine. 2: 274-5. PMID 26137566 DOI: 10.1016/j.ebiom.2015.03.018  0.379
2015 Paik JJ, Wigley FM, Lloyd TE, Corse AM, Casciola-Rosen L, Shah AA, Boin F, Hummers LK, Mammen AL. The spectrum of muscle histopathologic findings in 42 weak scleroderma patients. Arthritis Care & Research. PMID 25989455 DOI: 10.1002/acr.22620  0.423
2015 Lloyd TE, Christopher-Stine L, Pinal-Fernandez I, Tiniakou E, Petri M, Baer A, Danoff S, Pak K, Casciola-Rosen L, Mammen AL. Cytosolic 5'-nucleotidase 1A is a common target of circulating autoantibodies in several autoimmune diseases. Arthritis Care & Research. PMID 25892010 DOI: 10.1002/Acr.22600  0.645
2015 Ramanathan S, Langguth D, Hardy TA, Garg N, Bundell C, Rojana-Udomsart A, Dale RC, Robertson T, Mammen AL, Reddel SW. Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy. Neurology® Neuroimmunology & Neuroinflammation. 2: e96. PMID 25866831 DOI: 10.1212/NXI.0000000000000096  0.383
2015 Nichols L, Pfeifer K, Mammen AL, Shahnoor N, Konersman CG. An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy. Journal of General Internal Medicine. PMID 25855481 DOI: 10.1007/s11606-015-3303-9  0.443
2015 Chung T, Christopher-Stine L, Paik JJ, Corse A, Mammen AL. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle & Nerve. PMID 25737145 DOI: 10.1002/mus.24642  0.435
2015 Nance JR, Mammen AL. Diagnostic evaluation of rhabdomyolysis. Muscle & Nerve. 51: 793-810. PMID 25678154 DOI: 10.1002/mus.24606  0.379
2015 De Bleecker JL, De Paepe B, Aronica E, de Visser M, Amato A, Aronica E, Benveniste O, De Bleecker J, de Boer O, De Paepe B, de Visser M, Dimachkie M, Gherardi R, Goebel HH, ... ... Mammen A, et al. 205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands. Neuromuscular Disorders : Nmd. 25: 268-72. PMID 25572016 DOI: 10.1016/J.Nmd.2014.12.001  0.427
2015 Mohassel P, Rosen P, Casciola-Rosen L, Pak K, Mammen AL. Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle. Arthritis & Rheumatology (Hoboken, N.J.). 67: 266-72. PMID 25186009 DOI: 10.1002/art.38863  0.371
2015 Mammen A. SP0146 Drugs Causing Muscle Disease Annals of the Rheumatic Diseases. 74: 36.3-36. DOI: 10.1136/annrheumdis-2015-eular.6761  0.414
2014 Roda RH, Schindler AB, Blackstone C, Mammen AL, Corse AM, Lloyd TE. Laing distal myopathy pathologically resembling inclusion body myositis. Annals of Clinical and Translational Neurology. 1: 1053-8. PMID 25574480 DOI: 10.1002/Acn3.140  0.362
2014 Johnson C, Connors GR, Oaks J, Han S, Truong A, Richardson B, Lechtzin N, Mammen AL, Casciola-Rosen L, Christopher-Stine L, Danoff SK. Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type. Respiratory Medicine. 108: 1542-8. PMID 25269710 DOI: 10.1016/j.rmed.2014.09.003  0.386
2014 Mammen AL. Necrotizing myopathies: beyond statins. Current Opinion in Rheumatology. 26: 679-83. PMID 25203117 DOI: 10.1097/BOR.0000000000000106  0.449
2014 Sharma K, Orbai AM, Desai D, Cingolani OH, Halushka MK, Christopher-Stine L, Mammen AL, Wu KC, Zakaria S. Brief report: antisynthetase syndrome-associated myocarditis. Journal of Cardiac Failure. 20: 939-45. PMID 25084215 DOI: 10.1016/J.Cardfail.2014.07.012  0.403
2014 Albayda J, Mammen AL. Is statin-induced myositis part of the polymyositis disease spectrum? Current Rheumatology Reports. 16: 433. PMID 24996782 DOI: 10.1007/s11926-014-0433-8  0.468
2014 Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA. Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology. 83: 426-33. PMID 24975859 DOI: 10.1212/WNL.0000000000000642  0.381
2014 Musset L, Miyara M, Benveniste O, Charuel JL, Shikhman A, Boyer O, Fowler R, Mammen A, Phillips J, Mahler M. Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies. Journal of Immunology Research. 2014: 405956. PMID 24741598 DOI: 10.1155/2014/405956  0.363
2014 Paik JJ, Mammen AL, Wigley FM, Gelber AC. Myopathy in scleroderma, its identification, prevalence, and treatment: lessons learned from cohort studies. Current Opinion in Rheumatology. 26: 124-30. PMID 24419752 DOI: 10.1097/BOR.0000000000000024  0.412
2014 Paik JJ, Corse AM, Mammen AL. The co-existence of myasthenia gravis in patients with myositis: a case series. Seminars in Arthritis and Rheumatism. 43: 792-6. PMID 24412588 DOI: 10.1016/j.semarthrit.2013.12.005  0.378
2014 Pinal-Fernandez I, Grande MD, Filippo DG, Carrino JA, Mammen AL, Lloyd TE, Christopher-Stine L. FRI0483 Association between Muscle Enzymes, Acute-Phase Reactants and MRI Findings in Myositis Annals of the Rheumatic Diseases. 73: 562-562. DOI: 10.1136/Annrheumdis-2014-Eular.5569  0.63
2014 Pinal-Fernandez I, Christopher-Stine L, Casciola-Rosen L, Corse A, Mammen AL. AB0623 Correlating Muscle Biopsy Features with Autoantibodies in Patients with Dermatomyositis and the Jo-1 Antisynthetase Syndrome Annals of the Rheumatic Diseases. 73: 1011-1012. DOI: 10.1136/Annrheumdis-2014-Eular.5508  0.687
2014 Harrington C, Kuten D, Crystal J, Owoyemi K, Mammen A, Christopher-Stine L, Hirsch G, Schulman S. ELECTROCARDIOGRAPHIC ABNORMALITIES IN IDIOPATHIC INFLAMMATORY MYOPATHIES Journal of the American College of Cardiology. 63: A1635. DOI: 10.1016/S0735-1097(14)61638-7  0.353
2014 Sharma K, Orbai A, Desai D, Cingolani O, Halushka M, Christopher-Stein L, Mammen A, Wu K, Zakaria S. THE BODYBUILDER WHO COULDN’T LIFT: ANTISYNTHETASE SYNDROME-ASSOCIATED MYOCARDITIS Journal of the American College of Cardiology. 63: A617. DOI: 10.1016/S0735-1097(14)60617-3  0.334
2013 Mohassel P, Mammen AL. The spectrum of statin myopathy. Current Opinion in Rheumatology. 25: 747-52. PMID 24061077 DOI: 10.1097/01.bor.0000434673.85515.89  0.407
2013 Fiorentino DF, Chung LS, Christopher-Stine L, Zaba L, Li S, Mammen AL, Rosen A, Casciola-Rosen L. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ. Arthritis and Rheumatism. 65: 2954-62. PMID 24037894 DOI: 10.1002/Art.38093  0.362
2013 Subhawong TK, Wang X, Machado AJ, Mammen AL, Christopher-Stine L, Barker PB, Carrino JA, Fayad LM. 1H Magnetic resonance spectroscopy findings in idiopathic inflammatory myopathies at 3 T: feasibility and first results. Investigative Radiology. 48: 509-16. PMID 23563194 DOI: 10.1097/RLI.0b013e3182823562  0.358
2013 Mohassel P, Mammen AL. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. Muscle & Nerve. 48: 477-83. PMID 23519993 DOI: 10.1002/mus.23854  0.413
2012 Casciola-Rosen L, Mammen AL. Myositis autoantibodies. Current Opinion in Rheumatology. 24: 602-8. PMID 22955022 DOI: 10.1097/BOR.0b013e328358bd85  0.345
2012 Werner JL, Christopher-Stine L, Ghazarian SR, Pak KS, Kus JE, Daya NR, Lloyd TE, Mammen AL. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis and Rheumatism. 64: 4087-93. PMID 22933019 DOI: 10.1002/art.34673  0.358
2012 Ostrow LW, Corse AM, Morrison BM, Huff CA, Carrino JA, Hoke A, Mammen AL. Expanding the spectrum of monoclonal light chain deposition disease in muscle. Muscle & Nerve. 45: 755-61. PMID 22499107 DOI: 10.1002/mus.23287  0.391
2012 Mammen AL, Gaudet D, Brisson D, Christopher-Stine L, Lloyd TE, Leffell MS, Zachary AA. Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Care & Research. 64: 1233-7. PMID 22422616 DOI: 10.1002/Acr.21671  0.308
2012 Mammen AL, Pak K, Williams EK, Brisson D, Coresh J, Selvin E, Gaudet D. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care & Research. 64: 269-72. PMID 21972203 DOI: 10.1002/Acr.20662  0.329
2012 Williams KM, Ostrow LW, Loeb DM, Chung T, Cohn RD, Corse AM, Mammen AL, Chen AR. Immunohistochemistry of affected tissue may guide cGVHD treatment decisions. Bone Marrow Transplantation. 47: 731-3. PMID 21927032 DOI: 10.1038/bmt.2011.164  0.324
2011 Del Grande F, Carrino JA, Del Grande M, Mammen AL, Christopher Stine L. Magnetic resonance imaging of inflammatory myopathies. Topics in Magnetic Resonance Imaging : Tmri. 22: 39-43. PMID 22648079 DOI: 10.1097/RMR.0b013e31825b2c35  0.364
2011 Mammen AL, Mahoney JA, St Germain A, Badders N, Taylor JP, Rosen A, Spinette S. A novel conserved isoform of the ubiquitin ligase UFD2a/UBE4B is expressed exclusively in mature striated muscle cells. Plos One. 6: e28861. PMID 22174917 DOI: 10.1371/Journal.Pone.0028861  0.34
2011 Mammen AL. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nature Reviews. Neurology. 7: 343-54. PMID 21654717 DOI: 10.1038/nrneurol.2011.63  0.469
2011 Moghekar A, Rao S, Li M, Ruben D, Mammen A, Tang X, O'Brien RJ. Large quantities of Abeta peptide are constitutively released during amyloid precursor protein metabolism in vivo and in vitro. The Journal of Biological Chemistry. 286: 15989-97. PMID 21454701 DOI: 10.1074/Jbc.M110.191262  0.422
2011 Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, Casciola-Rosen LA. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis and Rheumatism. 63: 713-21. PMID 21360500 DOI: 10.1002/Art.30156  0.458
2010 Mammen AL, Amato AA. Statin myopathy: a review of recent progress. Current Opinion in Rheumatology. 22: 644-50. PMID 20827205 DOI: 10.1097/BOR.0b013e32833f0fc7  0.406
2010 Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care & Research. 62: 1328-34. PMID 20506493 DOI: 10.1002/acr.20219  0.394
2010 Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis and Rheumatism. 62: 2757-66. PMID 20496415 DOI: 10.1002/art.27572  0.443
2010 Mammen AL. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Annals of the New York Academy of Sciences. 1184: 134-53. PMID 20146695 DOI: 10.1111/j.1749-6632.2009.05119.x  0.434
2009 Mammen AL, Casciola-Rosen LA, Hall JC, Christopher-Stine L, Corse AM, Rosen A. Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle. Arthritis and Rheumatism. 60: 3784-93. PMID 19950298 DOI: 10.1002/Art.24977  0.391
1999 Mammen AL, Kamboj S, Huganir RL. Protein phosphorylation of ligand-gated ion channels. Methods in Enzymology. 294: 353-70. PMID 9916238 DOI: 10.1016/S0076-6879(99)94022-3  0.606
1997 Mammen AL, Kameyama K, Roche KW, Huganir RL. Phosphorylation of the alpha-amino-3-hydroxy-5-methylisoxazole4-propionic acid receptor GluR1 subunit by calcium/calmodulin-dependent kinase II. The Journal of Biological Chemistry. 272: 32528-33. PMID 9405465 DOI: 10.1074/Jbc.272.51.32528  0.654
1997 Mammen AL, Huganir RL, O'Brien RJ. Redistribution and stabilization of cell surface glutamate receptors during synapse formation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 7351-8. PMID 9295381 DOI: 10.1523/Jneurosci.17-19-07351.1997  0.556
1997 O'Brien RJ, Mammen AL, Blackshaw S, Ehlers MD, Rothstein JD, Huganir RL. The development of excitatory synapses in cultured spinal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 7339-50. PMID 9295380 DOI: 10.1523/Jneurosci.17-19-07339.1997  0.628
1996 Ehlers MD, Mammen AL, Lau LF, Huganir RL. Synaptic targeting of glutamate receptors. Current Opinion in Cell Biology. 8: 484-9. PMID 8791455 DOI: 10.1016/S0955-0674(96)80024-X  0.666
1996 Lau LF, Mammen A, Ehlers MD, Kindler S, Chung WJ, Garner CC, Huganir RL. Interaction of the N-methyl-D-aspartate receptor complex with a novel synapse-associated protein, SAP102. The Journal of Biological Chemistry. 271: 21622-8. PMID 8702950 DOI: 10.1074/Jbc.271.35.21622  0.666
1996 Roche KW, O'Brien RJ, Mammen AL, Bernhardt J, Huganir RL. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron. 16: 1179-88. PMID 8663994 DOI: 10.1016/S0896-6273(00)80144-0  0.649
Show low-probability matches.